article thumbnail

BioNTech and DualityBio team up to develop ADC therapeutics for cancer

Pharmaceutical Technology

BioNTech has signed exclusive licence and collaboration agreements with Duality Biologics (DualityBio) for the development of two antibody-drug conjugate (ADC) assets for solid tumours. The agreements also include the manufacturing and commercialisation of the two assets, including DB-1303 and DB-1311, across the globe.

article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Presenting quantitative information increased participants’ gist and verbatim recall of drug efficacy. ” Uh…no.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA completes inspection of Nexus’ manufacturing facility in US

Pharma Leaders

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. It is specialised in innovative processes for producing difficult-to-manufacture speciality and generic drugs.

article thumbnail

SERB Pharmaceuticals acquires US rights for bentracimab from SFJ

Pharmaceutical Technology

Speciality pharmaceutical company SERB Pharmaceuticals has acquired exclusive US rights for bentracimab from SFJ Pharmaceuticals. In partnership with SERB Pharmaceuticals, the company will also file a biologics licence application (BLA) to the US Food and Drug Administration (FDA) later this year.

article thumbnail

FDA grants approval for Amylyx’s Relyvrio to treat ALS

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS).

article thumbnail

Torrent Pharma to acquire Curatio for $245.16m

Pharmaceutical Technology

A flagship company of the Torrent Group, Torrent Pharmaceuticals is a speciality-focused firm with more than 74% of its revenue from chronic and sub-chronic therapies in India. Among these facilities, four are approved by the US Food and Drug Administration (FDA).

article thumbnail

Myovant rejects Sumitovant and Sumitomo’s $2.5bn acquisition offer

Pharmaceutical Technology

The board of directors of Myovant constituted a special committee of independent directors including its audit committee members to assess the proposal. The special committee decided that the deal substantially undervalues Myovant and is not in the firm’s or its minority shareholders’ best interests.